FdaApplication
NDA 022064
Identifiers
- fda_app_no: NDA022064
Properties
| Property | Value |
|---|---|
| applicant_name | CHATTEM INC DBA SANOFI CONSUMER HEALTHCARE |
| application_type | NDA |
| approval_date | 2007-05-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| XYZAL | LEVOCETIRIZINE DIHYDROCHLORIDE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
1 product